Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NEFFY 1 MG/0.1 ML NASAL SPRAY

epinephrine
$359.4900per EA

Strength

1 mg/100uL

Manufacturer

ARS Pharmaceuticals Operations, Inc.

NDC

82580001002

Classification

Brand

Dosage Form

SPRAY

Route

NASAL

Last Updated

1/1/2026

Active Ingredients

EPINEPHRINE

Approval Type

New Drug (NDA)

FDA Application

NDA214697

On Market Since

3/5/2025

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Catecholamine
Catecholamines
alpha-Adrenergic Agonist
beta-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

+5.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NINJACOF-D LIQUID
Brand
23359003416•Centurion Labs, LLC
$0.0825
per ML
VANACOF LIQUID
Brand
58809099901•GM Pharmaceuticals, INC
$0.0993
per ML
ADVIL COLD & SINUS CAPLET
Brand
00573018010•Haleon US Holdings LLC
$0.2615
per EA
ADVIL COLD & SINUS CAPLET
Brand
00573018021•Haleon US Holdings LLC
$0.2615
per EA
XYLOCAINE 2%-EPI 1:100,000
Brand
63323048327•Fresenius Kabi USA, LLC
$0.2655
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048226•Fresenius Kabi USA, LLC
$0.2721
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048227•Fresenius Kabi USA, LLC
$0.2721
per ML
ADVIL COLD-SINUS LIQUI-GELS
Brand
00573018432•Haleon US Holdings LLC
$0.2968
per EA
CAPMIST DM TABLET
Brand
29978060190•Capital Pharma
$0.3171
per EA
ADVIL ALLERGY SINUS CAPLET
Brand
00573018810•Haleon US Holdings LLC
$0.4772
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy